FDA Orange Book · active-ingredient family
Ropivacaine hydrochloride
Ropivacaine hydrochloride: 1 brand, 16 generics; first approved Sep 24, 1996; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 16 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
1
Generics (ANDA)
16
Listed patents
1
Next patent expiry
Nov 28, 2026
in 1 mo
Brand (NDA) products
Originator applications
- NAROPINRLDFRESENIUS KABI USANDA 020533201113 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG/10ML (2MG/ML) SOLUTION INJECTION Rx AP 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 100MG/20ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Rx AP 100MG/10ML (10MG/ML) SOLUTION INJECTION Rx AP 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 500MG/100ML (5MG/ML) SOLUTION INJECTION Rx AP 1GM/200ML (5MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP 75MG/10ML (7.5MG/ML) SOLUTION INJECTION Discontinued — 50MG/10ML (5MG/ML) SOLUTION INJECTION Discontinued —
Generic (ANDA) products (16)
Abbreviated applications
- ROPIVACAINE HYDROCHLORIDEANTHEA PHARMAANDA 21988320255 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP 20MG/10ML (2MG/ML) SOLUTION INJECTION Rx AP 100MG/20ML (5MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEHIKMAANDA 21190720243 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP 500MG/100ML (5MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEKINDOSANDA 21871320247 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG/10ML (2MG/ML) SOLUTION INJECTION Rx AP 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 100MG/20ML (5MG/ML) SOLUTION INJECTION Rx AP 100MG/10ML (10MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEMYLAN LABS LTDANDA 20609120232 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEAMNEALANDA 21660520234 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP 500MG/100ML (5MG/ML) SOLUTION INJECTION Rx AP 1GM/200ML (5MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEGLANDANDA 21010220222 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEHIKMAANDA 21407420204 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDECAPLINANDA 21280820206 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 100MG/20ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDESOMERSET THERAPS LLCANDA 20763620187 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG/10ML (2MG/ML) SOLUTION INJECTION Rx AP 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 100MG/20ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Rx AP 100MG/10ML (10MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEINFORLIFEANDA 20616620184 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP 500MG/100ML (5MG/ML) SOLUTION INJECTION Rx AP 1GM/200ML (5MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDERISINGANDA 20463620182 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 400MG/200ML (2MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEEUGIA PHARMAANDA 20561220167 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/20ML (2MG/ML) SOLUTION INJECTION Rx AP 200MG/100ML (2MG/ML) SOLUTION INJECTION Rx AP 100MG/20ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Rx AP 100MG/10ML (10MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDERISINGANDA 2039552016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP - ROPIVACAINE HYDROCHLORIDEHOSPIRAANDA 09019420146 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG/10ML (2MG/ML) SOLUTION INJECTION Discontinued — 150MG/30ML (5MG/ML) SOLUTION INJECTION Discontinued — 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Discontinued — 100MG/10ML (10MG/ML) SOLUTION INJECTION Discontinued — 40MG/20ML (2MG/ML) SOLUTION INJECTION Discontinued — 200MG/20ML (10MG/ML) SOLUTION INJECTION Discontinued — - ROPIVACAINE HYDROCHLORIDERISINGANDA 09031820144 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/20ML (2MG/ML) SOLUTION INJECTION Discontinued — 150MG/30ML (5MG/ML) SOLUTION INJECTION Discontinued — 150MG/20ML (7.5MG/ML) SOLUTION INJECTION Discontinued — 200MG/20ML (10MG/ML) SOLUTION INJECTION Discontinued — - ROPIVACAINE HYDROCHLORIDENAVINTA LLCANDA 07860120142 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG/30ML (5MG/ML) SOLUTION INJECTION Rx AP 200MG/20ML (10MG/ML) SOLUTION INJECTION Rx AP
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 7857802 | in 1 mo | Product |
Approval history
FDA approval span
First approval
30 yr 6 mo ago
Most recent approval
1 yr ago
Approvals span 1996–2025 across 17 FDA applications.
Brand (NDA) 16%
Generic (ANDA) 1694%
Ropivacaine hydrochloride: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Go beyond the database.
Try Assyro Intelligence for your regulatory research. Ready to discuss your team’s workflow? Book a demo.